Total Funding
34
73
Total FundingVenture - Series Unknown raised
Growth Score
-7 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
100782
Synova Life Sciences is developing a novel non-enzymatic device to obtain stem cells from adipose tissue for medical research and therapy.
Eric Hubbard: Business & Science Specialist- Mark Richman: Chief Clinical Officer
About the Company
Synova Life Sciences device that gets stem cells from fat. It's 30 times faster than the current gold standard and typically yields 1.5 to 2.5 times more cells. Processing takes less than 3 minutes and uses no enzymes or other chemical additives.
